KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) FCF Margin: 2010-2024

Historic FCF Margin for TherapeuticsMD (TXMD) over the last 15 years, with Dec 2024 value amounting to 66.44%.

  • TherapeuticsMD's FCF Margin rose 14040.00% to 127.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 74.96%, marking a year-over-year increase of 31350.00%. This contributed to the annual value of 66.44% for FY2024, which is 183917.00% up from last year.
  • Per TherapeuticsMD's latest filing, its FCF Margin stood at 66.44% for FY2024, which was up 103.75% from -1,772.73% recorded in FY2023.
  • In the past 5 years, TherapeuticsMD's FCF Margin registered a high of 66.44% during FY2024, and its lowest value of -2,144.07% during FY2021.
  • Its 3-year average for FCF Margin is -564.31%, with a median of 13.38% in 2022.
  • In the last 5 years, TherapeuticsMD's FCF Margin tumbled by 189,793bps in 2021 and then surged by 215,745bps in 2022.
  • Yearly analysis of 5 years shows TherapeuticsMD's FCF Margin stood at -246.14% in 2020, then crashed by 189,793bps to -2,144.07% in 2021, then soared by 215,745bps to 13.38% in 2022, then tumbled by 178,611bps to -1,772.73% in 2023, then skyrocketed by 183,917bps to 66.44% in 2024.